Summary /J2-Microglobulin-deficient (Bzm -/-) mice are reported to hck cell surface expression of major histocompatibility complex (MHC) class I molecules, CD8 + T cells, and the ability to mount MHC class I-specific T cell responses. We have observed that B2m -/-mice possess CD8 + T cells that can be induced to perform strong allospecific cytotoxic responses against nonself-MHC dass I by in vivo priming. We report that these B2m -/-cytotoxic T lymphocyte (CTL) differ from those induced in Bzm-positive littermates in that they cross-react and kill calls expressing self-MHC class I at normal ligand density with ~2m. B2m -/-CTL could even be induced in primary mixed lymphocyte culture by sdf-MHC dass I expressing stimulator cells, whereas allogeneic stimulator cells failed to elicit a response under similar conditions. Cells with a reduced cell surface MHC class I expression were less sensitive, while syngeneic B2m -/-cells were resistant to the ~2m -/-CTL. This antisdf-MHC reactivity could not be induced when ~/2m -/-T cells matured in an environment with normal MHC class I expression in bone marrow chimeric mice. Antisdf-MHC reactivity was also observed against human peptide loading-deficient cells expressing the appropriate murine class I molecules, suggesting that affinity to sdf-MHC class I may occur irrespective of peptide content. The results fit with a model where positive and negative selection of CD8 + T cells in B2m -/-mice is mediated by low levels of MHC class I free heavy chains. In this model, low ligand density on selecting cells leads to positive selection of rare T cells that bind to low levels of MHC class I free heavy chains, resulting in a very small peripheral CD8 + compartment. Due to low density of the selecting ligand, negative selection does not remove T cells recognizing Bzm-positive cells expressing self-MHC class I at normal ligand density, which generates a T cell repertoire that would be autoreactive in a B2m-positive littermate. The first "MHC deficient" animals thus paradoxically provide a tool for direct demonstration and analysis of self MHC bias in the T cell repertoire.
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M
HC class I molecules are expressed on virtually all nucleated mammalian cells (1) ./~2m, the membraneanchored heavy chain, and a short peptide are thought to assemble in the endoplasmatic reticulum where they form a complex that is transported to the cell surface (2) . All three subunits are necessary for ef~dent transport and surface expression of functional MHC class I molecules. Cell lines ddident in/~2m express little ff any MHC class I molecules detectable by mAbs at the cell surface (3) (4) (5) . Cells deficient in genes coding for transporter associated with antigen processing (TAP) 1 products involved in peptide loading also Mice lacking/3zm gene expression are virtually devoid of normaUy conformed MHC class I molecules at the cell surface and they have a drastically reduced number of CD8 + T cells in the periphery (12, 13) . This is regarded as a consequence of impaired positive selection in the absence of MHC class I molecules. In spite of this deficiency in CD8 + T ceUs, the mice reject grafts and resist many virus infections surprisingly well (14) (15) (16) (17) . In view of this, as weU as the recent observations that CD8 + T calls can recognize/3zm -/-cells in an MHC-spedfic or -restricted manner, we decided to investigate CD8 + T cells and their specificity in/3zm -/-mice. We reasoned that if free MHC class I heavy chains can reach the cell surface and be recognized by CTL, they may also play a role during sdection of CD8 + T ceils. If indeed/3zm -/-mice would be able to positively sdect a pool of CD8 + T calls, it would be important to investigate tolerance, with respect to MHC class I of the sdf genotype, in order to assess the efficiency of negative selection. We observed strong allospecific CD8 + CTL responses in ~2m -/-mice, as recently also shown by Apasov et al. (18) . Our study demonstrates that such CTL spedfacally recognize MHC class I molecules not only of the appropriate allogeneic type used in the priming step, but also the self type when these are expressed with /3zm at normal ligand density. Our results provide evidence for a functional sdection process of CD8 + T calls in /Szm -/-mice resulting in a skewed repertoire with respect to tolerance to syngeneic MHC class I products.
Materiah and Methods
Mice. All mice were bred and maintained at the Department of Tumor Biology, Karolinska Institutet. The generation of the /32m -/-mice has been described previously (19) . We denote /~2m -/-and/Szm +/-for mice being homozygous or heterozygous for the ~2m mutation. Cell Lines. P815 is a mastocytoma ~ line derived from DBA (H-2d), and P1HTR is a subline of P815. These two cell lines gave similar results, and both are, for reasons of simplicity, denoted 1)815 in the tables of this paper. PlHTK-K s, PlHTK-KKA, and PlHTK-AAK are transfectants of PIHTK (20) , and were the kind gift from Hans Stauss (University College, London, UK). KKA is an e~on-shuffled construct containing the otl/c~2 domains of H-2K b, and the c~3 domain of HLA-A2. AAK is a construct containing the cd/tx2 domains of FILA-A2 and the ix3 domain of H-2KL FIHTK-D s and PlHTR-KS-D b are H-2D b and H-~ b, D b transfectants of PIHTK, respectively. El.,4 is a ben~induced lymphoma derived from B6, and EI,4D d is an H-2D a transfectant of EL-4. C4.4-25-is a/3zm -/-variant of EL-4, and E50.16 + is a/32m transfectant of C4. 4-25-(21) . C4.4-25-D a is an H-2D a transfectant of C4.4-25-. RMA is a subline of the Raucher Virus-induced ]36 lymphoma RBL-5, and KMA-S is a TAP2 loss mutant of RMA (2, (22) (23) (24) . T2 is a hybrid between the two human cell lines .174 and CEM, and has an antigen processing deficiency due to a deletion in the MHC class II region, including the TAFI and TAP2 genes (6, 7). T2-K b, T2-D b, T2-D a, and T2-DP are MHC class I transfectants of T2, kindly provided by Peter Cresswell (Yale University School of Medicine, New Haven, CT). T1 is the wild type of T2. T1-K b and T1-D a are MHC class I transfectants of T1. T1-K s was kindly provided by Frank Momburg and Gunther HLmmerling (Deutsche Krebsforschungszentrum DKFZ, Heidelberg, Germany). The generation of Con A-activated T cell blasts has been described (11) . Briefly, 15 x 10 ~ erytbrocytedepleted spleen cells were phted in each well in 12-well plates, in RPMI supplemented with 5/tg/ml Con A and 10% FCS. After 2-3 d the bhsts were used as targets in a SlCr release assay.
Transfection. 5 Synthetic Poytides. AU peptides were pro'chased from Chiton Mimotopes (Melbourne, Australia). The H-2K s and H-2D b bind-ing sequences were derived from the immunodominant epitopes of Sendal and A/PR./8/34 influenza viruses and were: FAPGNYPAL and ASNENMETM (in single letter amino acid code). NH2 and COOH terminals were free in both peptides.
E.~ctor Cells and Mixed Lymphocyte Culture (MLC).
Cold Target Competition Assa~ Effector cens and cold (unlabeled) target ceils were mixed and preincubated in 37~ for 60 min before addition of hot (StCr-labeled) target cells. Tumor cells or Con A blasts were used as cold targets. The cold Con A blasts used as cold targets were not cytotoxic to any of the targets used (data not shown).
Generation of Fibrosarcomas from/~zm -/-and ~2m +/-Mice.
Mice were injected intramuscularly with 0.05 mg of methylcholantrene dissolved in 0.1 ml olive oil. Fibrosarcomas developed after a period of 3-5 too. The tumors were adapted to in vitro culture and typed by Southern blot analysis for the/3zm genotype.
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Generation (Tables 1 and 2 ). The strength of the response was in the same range as that of effector cells derived from/3zm +/-or B6 control mice. The response was not dependent on epithelial cells or professional antigen-presenting cells among the allogeneic splenocytes used for priming and restimuhtion, as these could be substituted by the H-2a-expressing tumor P815, a CD4-CD8-mastocytoma (Tables 1-3) . However, the response was dependent on in vivo priming, since it was poor when unprimed spleen cells were used, as observed previously (data not shown, and reference 13). The CTL responses of/52m -/-mice have been observed in >30 consecutive experiments.
The in vivo priming of/~zm -/-mice resulted in a small but consistent increase in the number of CD8 + cells in the spleen so that these represented up to 3% of total spleen cells (not immunized: mean 1.1% CD8 + cells, range 0.2-1.6; immunized: mean 2.8% CD8 + cells, range 1.7-5.3). It should be noted that in absolute numbers the figures correspond to 2-5 • 106 CD8" cells and an increase of approximately twofold of the whole CD8 + population as a response to in vivo priming. A more dramatic effect was noted at the end of the in vitro restimulation, when/~2rn -/-CD8 + cells had expanded 4-10-fold to represent up to 34% of total cells in the culture (Fig. 1) . The CD8 + cells in this population were also TCIL-oe/O + , and the majority of the CD8-TCKce//3 + were CD4 + ( Fig. 1 and data not shown) . The cytotoxic/52m -/-effector cells were CD4-CD8 § , as determined by antibody and complement depletion of effector cells generated in the MLC (Table 1) , and MHC class I allospecific since they killed human T1 or T2 cells transfected with H-2D a, but not untransfected cells (Tables 2 and 4 ). CD4 + calls also expanded upon secondary in vitro allostimulation of/32m -/-spleen cells, which contrasted to the decreased proportion of CD4 + cells in the corresponding cultures of spleen cells from in vivo primed O2m +/-mice (data not shown). However, depletion of CD4 + ceils had no effect on allospecific cytotoxidty in this experimental system. /32m -/-CTL generated by allogeneic stimulation thus behaved as expected from classical MHC-specific alloreactive CTL, with respect to phenotype and MHC class I--oriented allospedficity.
CTL Generated from ~zm -/-(1"1-2 b) Mice Cross-react on Cells Expressing H.2 ~.
In contrast to the effector cells generated from the/~2m +/-litterrnates, anti-H-2a-primed/~zrn -/-CTL also killed target cells with call surface expression of H-2 b (i.e., self) and/32m at normal ligand density (H2b//Szm) ( Tables 1 and 2 ). This killing was dependent on a normal MHC class I expression since the/3zm -/-mutant of EL-4, C4.4-25-, was resistant, while the/3an transfectaut of C4.4-25-, with restored MHC class I expression, was sensitive (Table 2) . Furthermore, T2-K b cells were killed whereas T2 and T2-Dp were not (Table 2 ). When Con A blasts derived from MHC congeneic mice were used as targets, anti-H-2 a/~an -/-CTL showed a preference for Con A blasts expressing H-2 b antigens, whereas the syngeneic/~zm -/-(H-2 b) Con A blasts were resistant ( Table 2 ). The * Effector cells were generated as described in Materials and Methods. A/Sn splenocytes or P815 tumor cells were used for priming. The effector cell population was depleted from various cellular subsets using antibody and complement treatment. The EL-4 and P815 targets are of H-2 b and H-2 a haplotype, respectivdy. $ Percent specific lysis in a sICr release assay. E/T ratio: 60:1, 12:1. killing of H-2b-expressing targets was also mediated by CD4-CD8 + cells, as determined by complement-mediated depletion of the effector cell population (Table 1) . To study whether this killing was due to a unique cross-reactivity between H-2 b and H-2 a (as discussed in reference 25) we also generated Earn -/-CTL against AKR (H-2 k) or A.SW (H-2') spleen cells. The same pattern emerged: Ezra -/-(but not Ezra +/-) CTL killed targets expressing H-2b/ Ezra (data not shown).
CTL Killing Induced by Peptide or Cold Temperature Treatment of RMA-S.
The peptide loading (TAP2)-deficient mutant RMA-S (H-2b; references 2, 22-24) showed a low and somewhat variable sensitivity (range: 5-38% lysis) to the anti-H-2d-stimulated Ezm -/-CTL. RMA-S was dearly less sensitive than the wild type RMA line (50-80% lysis; Table  3 ), but neither tLMA nor RMA-S were sensitive to anti-H-2 d Earn +/-CTL ( Table 3) . Culture of ILMA-S at 26~ or in the presence of H-2K b and H-2D b binding synthetic peptides significantly increased the sensitivity of KMA-S to the Ezra -/-CTL, but not to Ezm +/-CTL. Both of these treatments stabilize MHC class I molecules at the surface of tLMA-S and increase their steady state expression (2, 26) . The ceU surface MHC class I levels induced by these treatments correspond to about half of what is expressed on wild type RMA cells. These observations suggest that E2m -/-CTL can recognize H-2K b and H-2D b molecules independently of specific peptides loaded internally in the MHC class I peptide presentation pathway, and that ligand density 665 Glas et al.
of MHC class I molecules may be crucial when they recognize cells expressing H-2b/fl2m. (1"1-2 b) CTL. We performed cold target competition experiments to test whether the killing of the allospecific H-2 d and the self-H-2b-expressing target was mediated by the same CTL. Bulk Ezm -/-CTL generated against 1)815 (H-2 a) kiUed EL-4 (H-2 b) as weU as P815-1abeled targets (Table 4) . Using EL-4 as a hot target, we observed that both EL-4 and P815, but not the Ezm -/-C4.4-25-, competed for these Ezra -/-CTL (Table 4 ). This shows that the bulk population contained CTL able to recognize the self-MHC-matched as well as the allospecific target. Using P815 as hot target, competition was seen only with 1)815, whether Ezm -/-or Ezm +/-CTL were used (data not shown). Competition experiments were also made with Ezm -/-CTL generated against AKK (H-2 k) spleen cells. These killed A.BY (H-2 b) in addition to AKK Con A blasts of the allospecific H-2 k type. Using A.BY as a hot target, both A.BY and AKR competed for these CTL, while third party A.CA (H-2 ~) Con A blasts did not (Fig. 2 A) . When AKK Con A blasts were used as hot targets, A.BY Con A blasts competed partially for E2m -/-CTL whih they cornpletdy failed to compete for Ezra +/-CTL generated under the same conditions ( Fig. 2 B and data not shown) . From the combined cold target competition experiments we conclude that anti-H-2a-primed CTL bnlk cultures generated from Ezm -/-H-2 b mice contain CD8 + CTL that Table 4 . ~2m -/-CTL Generated against Targets Lacking ~2m kill allospeciiic targets, of which some (but not all) crossreact on H-2b/flzm-expressing targets. (Table 4) . (Tables 2 and 5) , since the routine MHC class I molecules in T2-D b and T2-K b are considered to be devoid of peptides (27) . The data on the T2 transfectants, therefore, also argue against the possibility that the response was directed against minor histocompatibility antigens not shared by the/3zm -/-and B6 mice. When B6-derived EL-4 tumor cells were used as immunogens in order to dicit an H-2b-restricted CTL response in/$zm +/-mice, these CTL behaved differently from those induced in the same way from/3zm +/-mice. The/32m +/-CTL killed EL-4 but not T1-K b, presumably due to lack of tumor antigens (or other routine-specific peptides) expressed by EL-4 ( Table 5, Given the fact that fl2m -/-(H-2 b) CTL cross-react on H-2b/fl2m-expressing cells, one would suspect specificity for H-2 b in the fl2m -/-CD8 + spleen cell population in general. We tested if the flzm -/-spleen cells would in fact respond in a primary MLC against fl2m-positive H-2 b stimulator cells. For this we used fl2m -/-mice that had been backcrossed to B6 (H-2 b) for five generations (fl2m -/-B6 bc.5), fl~m -/-B6 bc.5 spleen cells generated almost no cytotoxic response when stimulated with irradiated DBA (H-2 d) spleen cells, which is in line with previously published data (13). However, a strong H-2b-specilic response developed when fl2m -/-B6 bc.5 spleen cells were stimulated with B6. This response was MHC class I specific since EL-4, but not C4.4-25-, was killed. Furthermore, P815 (H-2 d) was resistant while P815-KbD b was killed (Table  6 ). In reverse, normal B6 spleen cells generated a strong cytotoxic response to DBA but not to syngeneic B6 spleen cells. This indicates that the frequency of T cells in fl2m -/-mice with specificity for self-MHC class I/fl2m is higher than that for allogeneic MHC dass I/fl2m, whereas the situation is reversed in the fl2m-expressing mice.
Specificity for Both 1-1-2 a and 1-1-2 b among Individual ffzm -/-

Cross-reaction between H.2b/B2m Expressed at Normal Ligand Density and H-2IY
CTL Elicited by
Generation of H-2b-specific ~2m -/-(H.2b) CTL in a Primary MLC Using Syngeneic /~2m-positive Stimulator Cells.
fici~ of CTL Generated from ~m +/-and ff2m -/-Mice Immunized with H-2b-expressing Cells
Absence of H-2b-speci.fic Cross-reactivity among ffzm -/-CTL Maturing in a ~2m-positive Host. We finally asked whether the cross-reactive response to sdf-MHC class I molecules was intrinsic to flzm -/-CTL, or if it was influenced by other host cells. We derived bone marrow chimeras by reconstituting lethally irradiated B6 (H-2 b) mice with flzm -/-bone marrow cells. Analysis of spleen cells from these chimeras revealed that <5% flzm-positive cells were present (data not shown). The flzm -/-bone marrow almost fully reconstituted the CD8 compartment, representing 8-10% of all spleen calls, compared with flzm +/-mice that contain up to 15% CD8 + spleen cells. This implies that normal MHC class I expression on CD8 + T cells themselves is not needed for their devdopment, as previously observed in reference 28. After 8 wk, these mice, as well as flzm -/-and flzm +/-control mice, were immunized with P815 (H-2a), and tested as described above for fl2m -/-mice. In vitro restimulation of spleen cells from chimeric mice generated CTL that killed the specific target, P815, as did fl2m +/-CTL. The effector cells from the chimeric mice were H-2K b and H-2D b negative (Table 7) . In contrast to CTL from flzm -/-control mice, flzm -/-CTL that had matured in fl2m-positive hosts did not kill EL-4 cells, suggesting that developmental events regulate the sdf-reactivity of flzm -/-CTL.
Our results demonstrate that strong CTL responses can be induced in flzm -/-mice by in vivo priming and subsequent in vitro restimulation with allogeneic cells. This is in line with a recent report (18) demonstrating that CTL can be induced in the peritoneal exudate of fl2m -/-mice by intraperitoneal inoculation of tumor cells. In addition, our results provide: (a) a clear demonstration, through the use of MHC class I-transfected (MHC class II negative) ceils, that CTL in fl2m -/-mice can spedfically recognize MHC dass I molecules, and (b) evidence that some allospecific flzm -/-CTL cross-react specifically on fl2m-positive calls expressing sdf-MHC class I.
There are at least three different explanations for the existence of functional CD8 + CTL in fl2m -/-mice: (a) they do not arise from a CTL precursor pool present in the mice initially, but are rather induced from immature CD8 + CD4 + cells by the priming procedure; (b) they represent CD8 + cells that have matured and survived by chance, in a stochastic process independent of positive sdection by MHC class I molecules; and (c) they represent a pool of CD8 + CTL precursors sdected on low ligand density of H-2b-free heavy chains. We believe our data support the last explanation, for reasons outlined in the following discussion.
The current modds of T cell sdection are based on the idea that TCRs with too high affinity for self-MHC are negatively selected, while those with low to intermediate affinity are positively selected (29, 30) . There is evidence for a role of MHC-bound peptides in positive as well as negative selection, even if these processes are not completely understood (31, 32) . However, TCR affinity to MHC plus peptide is not the only determining factor; at the cellular level, total avidity is also influenced by the density of the selecting ligand and by accessory molecules such as CD4 and CD8 (33) . This predicts that a dramatic reduction in the density of ligand on the selecting cells should readjust the sdection window such that there would be a reduced probability of finding T cell precursors with high enough avidity for positive selection. At the same time there would be a reduced probability for negative selection of T cells, including those expressing TCR with considerable at~nity to self-MHC. These would escape elimination due to low total avidity. In other words, low MHC class I expression during T cell education would reduce the number of selected CD8 + cells, with the concomitant possibility that the few ceils that are selected might cross-react specifically on self-MHC class I when these molecules are expressed at normal ligand density. In contrast to the modds based on total absence of CD4-CD8 + T cells, or a randomly leaky, nonselected CD4-CD8 + T cell repertoire in B2m -/-mice (explanations a and b above), this model predicts a bias for self-MHC class I of the CTL repertoire in Bzm -/-mice. This is in line with what we observed in terms of H-2 b cross-reactive responses. It must then be assumed that low levels of free MHC class I heavy chains are used in positive and negative selection processes in Bzm -/-mice. This is well in line with available data showing that low levels of MHC class I free heavy chains indeed can be expressed on calls of Bzm -/-mice (10, 11) .
It is important to remember that as little as 200 MHC class I/peptide complexes on the surface of a target cell may trigger CTL lysis (34) , and it may be that comparable numbers of free MHC class I heavy chains can trigger selection signals.
Note that the CD8 + T cells of ~zm -/-mice were not generally cross-reactive, but showed a bias for H-2 b. In addition, this required MHC class I expression at normal levels with B2m; the mice were tolerant to ~2m -/-cells of H-2 b genotype, although these transport heavy chains to the cell surface that can be recognized by CD8 + CTL with allospecificity for H-2K b or H-2D b (10, 11) . These observations suggest that the small pool of CD8 + T ceils in these mice does not just represent random "leaking" but rather the con-sequence of negative and positive selection of TCR on low levels of free H-2 b MHC class I heavy chains. The determination of CD4 vs. CD8 phenotype of the T cells may still be based on a partly stochastic and partly selective process, as discussed recently (35, 36) . We suggest that in relation to self-MHC class I expressed with 132m at normal density, the skewed T cell selection window of/32m -/-mice has neglected a lot of the "useful" clones, while it failed to eliminate and rather positively selected the "harmful" ones (37) . The repertoire is however only harmful in relation to normal levels of class I molecules, and adequate in relation to the 13zm -/-self. 132m -/-CTL could thus distinguish between allo and self-MHC class I in 13zm -/-cells, but not when expressed at normal ligand density in 132m-positive cells. The importance of ligand density is illustrated by the reduced sensitivity of RMA-S compared with RMA and also by the enhanced sensitivity of RMA-S after incubation at reduced temperature or in the presence of H-2-binding peptides.
In addition to effects of low ligand density, there could also be qualitative effects due to the reduced ability of free MHC class I heavy chains on selecting cells in •2m -/-to present and tolerize for specific self-peptides (including peptides derived from the 132m molecule itself). CD8 + T cells specific for self-peptides might thus escape elimination, which would contribute to the cross-reactivity on cells expressing H-2 b class I molecules in association with/32m and peptide. It has been reported that CTL reactive against selfpeptides can be detected in the periphery of normal mice, only being reactive when target cells express an unphysiologically high density of a peptide/MHC complex, i.e., when they are supplied with large amounts of peptides exogenously (38) . In our system, however, the reactivity of 132m -/-CTL towards peptide loading-deficient RMA-S, T2-K b, and T2-D b cells argues against this qualitative model as the only explanation for the data. The data rather suggest that TCR affinity for self-MHC class I of B2m -/-CTL can be peptide independent. This is important for understanding of TCR-MHC class I interactions as well as the positively selected T cell repertoire. However, even if the/jam -/-CTL have TCRs capable of binding to empty H-2K b and H-2D b molecuhs, this does not necessarily mean that they have been selected on such molecules. If specific sdf-peprides are involved in positive selection, one would predict that these peptides should dramatically increase the killing of H-2 b targets by the/jam -/-CTL.
The observations on chimeric mice show that the antisdf-MHC crossreactivity is not a consequence of the/jzm/ MHC class I-deficient status of the CTL themselves. After maturing in the presence of normal/jam-positive calls, they behaved as normal CTL. This could be due to the influence of radioresistant nonhematopoetic cells, or of equally radioresistant bone marrow-derived cells of host type. Cells of the latter type are considered responsible for negative sdection in chimeras studied within a couple of months of reconstitution (29) .
How can these results and this model be reconciled with the initially reported absence of CD8 + T cells and CTL responses in lJam -/-mice? Scrutiny of the previously published data reveals CD8 staining of 1-2% of the spleen cells in such mice. This may be considered dose to background, especially if a modest number of cells analyzed yield only a few uncertain dots in a FACS | plot. It may however represent 1-3 x 106 cells in the spleen only, and a mere 10-25-fold reduction in number compared with wild type mice. This is a small reduction, considering that the frequency of precursors for H-2-restricted responses against viral or minor histocompatibility antigens are 20-200-fold lower than the frequency of allo H-2-specific precursors (39) . Yet, the former give rise to strong in vivo responses capable of dearing virus infections and rejecting millions of tumor cells. They also yield strong cytotoxic responses in vitro, although these show a strict requirement for in vivo priming, just as the allospecific responses in the present study of/jzm -/-mice. We conclude that the search for CD8 + cells and of CTL responses in immunodeficient mice should include FACS | analysis of a large number of cells as well as an in vivo priming step in functional studies. According to this view, the status of MHC class I-restricted cells in several gene knock out mice may still offer some surprises. There is for example an interesting possibility of a similar skewed repertoire selected on low levels of empty class I molecules in TAPl-deficient mice (40) .
It is possible that the relatively "normal" phenotype and immune resistance of/j2m -/-mice partly depends on free MHC class I heavy chains substituting for complete MHC class I complexes, thus generating a skewed CTL repertoire whose responses may not always be detected in the conventional in vitro assays. Although we failed to generate B2m -/-CTL using/j2m-deficient cells for priming in one combination, this needs further testing under conditions of adequate costimulation conditions, e.g., during the inflammatory response during a virus infection. Only CD4 + CTL have been reported in/j2m -/-infected mice so far (17) . Note that/jam -/-CTL could kill/j2m-deficient targets when they had been induced by/jam-positive allogeneic priming cells (Table 4) .
One reflection emerging from the proposed model concerns the flexibility of the immune system as the T cell precursor repertoire meets the selection machinery of the host and adapts to perform optimally in this environment. Even if the latter is MHC class I deficient as perceived by FACS | T cells apparently detect enough to go through the selection procedure, illustrating the fine tuning required when setting the limits of avidity for positive and negative selection windows. Finally, it is a common view that positive selection must bias the repertoire for binding to self-MHC irrespective of antigen, but this has been difficult to demonstrate. Even if conventional T cells can show a heteroclitic response on third party targets, they do not kill self (25) . Our results provide a demonstration of T cell recognition of self-class I products, even when expressed in peptide loading-deficient cells. This system may serve as a tool to further analyze the self-MI-IC bias of the T cell repertoire, a somewhat unexpected development for the first "MHC deficient" mice.
